Loading clinical trials...

Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma. | Clinical Trials | Clareo Health

COMPLETED

Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma.

Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma. A Comparative Analysis

NCT06330558•Zagazig University

Summary

Context: Adrenalectomy for pheochromocytoma (PHEO) poses difficulties due to the elevated chance of conversion. The objective of this study was to conduct a comparative analysis of the occurrence and determinants of conversion in left-sided abdominal laparoscopic adrenalectomy (LLA) and right-sided abdominal laparoscopic adrenalectomy (RLA). Methods: A retrospective analysis was conducted to include a total of 271 patients diagnosed with PHEO. These patients were separated into two groups: LRA (N=121) and LLA (N=150). The study period spanned from September 2016 to September 2023.

Detailed Description

The process of performing an adrenalectomy for pheochromocytoma (PHEO) is difficult due to the significant risk of conversion. The objective of this study was to conduct a comparative analysis of the occurrence and determinants of conversion in left-sided abdominal laparoscopic adrenalectomy (LLA) and right-sided abdominal laparoscopic adrenalectomy (RLA). Methods: A retrospective analysis was conducted to include a total of 271 patients diagnosed with PHEO. These patients were separated into two groups: LRA (N=121) and LLA (N=150). The study period spanned from September 2016 to September 2023.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Unilateral pheochromocytoma of any size, over 18 years old, both males and females

Exclusion Criteria

•Patients undergoing initial open adrenalectomy, - Additional surgical interventions during total laparoscopic adrenalectomy, - Partial adrenalectomy,
•Bilateral PHEOS. Hemorrhagic diathesis, Structural deformity Pregnancy,
•\- Prior unilateral abdominal surgery, data is absent. The preoperative diagnosis is ambiguous. Hereditary (PHEO), or recurrent PHEO

Key Dates

Start Date

September 1, 2016

Primary Completion Date

September 1, 2023

Completion Date

September 1, 2023

Last Updated

March 28, 2024

Enrollment

271

ACTUAL participants

Conditions

Adrenal Tumor

Interventions

laparoscopic right adrenalectomy

PROCEDURE

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

NCT06229405

Adrenal TumorPrimary Aldosteronism+3 more

View study

COMPLETED

Rare Cystic Benign Adrenal Incidentalomas

NCT03739918

Urologic DiseasesAdrenal Tumor

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 28, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma.

Inclusion Criteria

Exclusion Criteria

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

Rare Cystic Benign Adrenal Incidentalomas

Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy